Miraculins, Inc., a development stage company, engages in the discovery and development of therapeutics and diagnostics for human disorders. Prostate Cancer Program The company has an agreement with CMX Research, Inc., a site management organization (SMO), which is conducting pharmaceutical, biotech and medical device research at 32 locations across Canada. In 2007, the company filed a pre-IDE (Investigational Device Exemption) submission with the U.S. Food and Drug Administration, in preparation for its planned clinical study for its P2V prostate cancer diagnostic test. Colorectal Cancer Program The company owns intellectual property related to various biomarkers indicated for colorectal cancer and is executing a research program to validate the ability of these markers to diagnose this disease. The company has into a collaboration agreement with the Fox Chase Cancer Center for the validation phase of its research work. Pancreatic, Gastric, and Breast Cancer Programs The company has intellectual property related to pancreatic, gastric, and breast cancers that require research. It focuses on its prostate and colorectal cancer programs, and evaluates the next steps for these cancer programs. Other Opportunities In addition to research programs, the company has various complimentary patents cancer areas and is in the process of planning specific research programs that would verify the utility of this intellectual property. Significant Events On January 07, 2010, the company has entered into a partnership with Inverness Medical Innovations Inc. to advance and commercialize Miraculins' preeclampsia technology. History Miraculins, Inc. was incorporated in 1998.
(MOM:TSX Venture Exchange)
6-1250 Waverley Street
Winnipeg, MB R3T 6C6
|Health Discovery Corp||$0.02 USD||+0.0026|
|Imperial Innovations Group PLC||447.00 GBp||0.00|
|Myriad Genetics Inc||$33.73 USD||-0.34|
|Vermillion Inc||$1.81 USD||-0.05|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact MIRACULINS INC, please visit www.miraculins.com. Company data is provided by Capital IQ. Please use this form to report any data issues.